Navigation Links
Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
Date:11/19/2008

r receptor (c-kit), two proteins involved in cell proliferation.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disorder, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit http://www.amgen.com.

About Takeda

Located in Osaka, Japan, Takeda Pharmaceutical Company Limited (TSE:4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website, http://www.takeda.com.

About Millennium

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. Millennium Pharmaceuticals, Inc. was acquired by Takeda Pharmaceutical Company Ltd. in May, 2008. The Company's research, development and commercialization activities are focused in oncology. Additional information about Millennium is available through its webs
'/>"/>

SOURCE Amgen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
2. Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
3. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
4. Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
5. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
6. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
7. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
8. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
9. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
10. Raptor Pharmaceuticals Provides Update on Targeting Platforms
11. New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Levi & ... Pharmaceutical, Inc. (NASDAQ: OHRP ) concerning possible violations ... issued by the Company in connection with its study ... TO: http://zlk.9nl.com/ohr-pharmaceutical-ohrp or contact Joseph E. ... or by telephone at (212) 363-7500, toll-free: (877) ...
(Date:3/27/2015)... , March 27, 2015  Holographic Optical Technologies of ... field of holographic medical imaging, is entering the world ... campaign. Launching on April 20 th , 2015, the ... Pro. The 8-inch and 22-inch displays will allow consumers ... the first time. In addition to the two displays, ...
(Date:3/27/2015)... 2015 A new report from Kalorama Information says ... – Chile , Colombia ... for IVD firms.  The healthcare research firm said that while ... for the Latin American continent with a population of over ... operations. However, the country,s regional economic clout does not necessarily ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... BETHLEHEM, Pa., Oct. 26 A landmark study ... French hospitals over a two-year period has confirmed ... offer significantly better protection against accidental needlestick injuries ... as semi-automatic (push-button) devices or those with manually ...
... Md., Oct. 26 MedAvante, Inc., the leader ... (CNS) disorders, and Rexahn Pharmaceuticals, Inc. (NYSE Amex: ... company developing and commercializing potential best in class ... use MedAvante ,s Remote Centralized Ratings™ in their ...
Cached Medicine Technology:Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention 2Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention 3Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention 4Rexahn to Use MedAvante Centralized Ratings in MDD Phase 2b Study 2Rexahn to Use MedAvante Centralized Ratings in MDD Phase 2b Study 3
(Date:3/29/2015)... March 29, 2015 Adults who are ... promote nationally on the web can now use the ... insurance quotes can now be explored while researching the ... , Learning the differences between what a term policy ... a challenge for some men and women. Insurers typically ...
(Date:3/29/2015)... Chicago, IL (PRWEB) March 29, 2015 ... Foundation for Women’s Cancer announce today that ... 2015 recipient of the Claudia Cohen Research Foundation Prize ... presented at the Society of Gynecologic Oncology 46th Annual ... is Director of the Cedars-Sinai Women’s Cancer Program at ...
(Date:3/29/2015)... Washington, D.C. USA (PRWEB) March 29, 2015 ... Afro Health Link platform provides basic health ... them the opportunity to discuss these challenges as ... them. Afro Health Link addresses six medical conditions ... and encourage users to engage in conversations around ...
(Date:3/29/2015)... 29, 2015 North American Seminars receives ... Online Continuing Education Courses . , Utilizing ... CME - TPTA, approval # 56399TX      , ... the shoulder complex - 10.5 hours - Texas Board ... Examination and Treatment of the SI Joint - 10 ...
(Date:3/28/2015)... 2015 Coffee could not only perk you ... from gum disease, researchers have found. , They found that ... Coffee contains antioxidants. Antioxidants fight gum disease. Does coffee, then, ... Boston Univ. Henry M. Goldman School of Dental Medicine explored ... issue of the Journal of Periodontology. , “This is the ...
Breaking Medicine News(10 mins):Health News:Permanent Life Insurance Quotes Now Offered Through Web Search System at Insurer Website Online 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 3Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2
... ... injury attorney, results in payment to an underage passenger hurt in a vehicle crash after ... ... Mark Gemma underscores the liability homeowners face when they allow underage drinking in ...
... ... latest information about clinics, camps, academies and events at Sea Colony - The Premier ... just north of Ocean City, Maryland. , ... Sea Colony, Bethany Beach, Del. (PRWEB) February 12, 2010 -- ...
... ANDREWS, Texas , Feb. 11 It took the jury ... for Anne Mitchell, RN , defendant in the criminal trial that ... trial. Mitchell faced a third-degree felony charge in Texas of ... Board for what she believed was unsafe patient care. Mitchell is a ...
... coronary artery , THURSDAY, Feb. 11 (HealthDay News) -- Former ... Thursday evening in a New York City hospital after he ... , The 63-year-old Clinton, who underwent quadruple bypass surgery in ... reports. , "Today President Bill Clinton was admitted to ...
... , , , ... 11 /PRNewswire-Asia-FirstCall/ -- China Cord Blood,Corporation ("CCBC" or ... leading provider of,cord blood collection, laboratory testing, hematopoietic ... that the Securities and,Exchange Commission ("SEC") declared the Company,s ...
... stress disorder (PTSD) threatens to overload healthcare and ... cases rises and existing treatments are not sufficiently ... technology, such as virtual reality, to alleviate the ... solutions are explored in a special issue of ...
Cached Medicine News:Health News:Rhode Island Settlement Reflects Homeowner Liability for Serving Alcohol to Those Under 21, Says Providence Lawyer Mark Gemma 2Health News:New SeaColonyTennis.net Launches to Promote World-Class Tennis Programs at Sea Colony 2Health News:Not Guilty - Texas Jury Acquits Winkler County Nurse 2Health News:Not Guilty - Texas Jury Acquits Winkler County Nurse 3Health News:Ex-President Clinton Undergoes Heart Procedure 2Health News:China Cord Blood Corporation Warrant Registration Statement Declared Effective by SEC 2Health News:Virtual reality and other technologies offer hope 2
... Analyzer II is a ... to enumerate fluorescently labeled ... selected and aligned. The ... CellTracks® Analyzer II, a ...
... These unique Acid Fast ... sputum smear with appropriate background ... containing a positive and negative ... Kinyoun (Cat. No. 353), Ziehl-Neelsen ...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Medicine Products: